| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |